Lataa...
Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia
The naturally occurring oncolytic virus (OV), reovirus, replicates in cancer cells causing direct cytotoxicity, and can activate innate and adaptive immune responses to facilitate tumour clearance. Reovirus is safe, well tolerated and currently in clinical testing for the treatment of multiple myelo...
Tallennettuna:
| Julkaisussa: | Leukemia |
|---|---|
| Päätekijät: | , , , , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4490165/ https://ncbi.nlm.nih.gov/pubmed/25814029 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2015.88 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|